Delivery Order SPE2DR25D3014-SPE2DR26FP1KB
Award Date 12/18/25
Potential Completion Date 12/19/25
Potential Value $2.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a biologic immunosuppressant medication used to treat autoimmune conditions. This firm fixed-price delivery order carries a ceiling value of $5,204.35 and is scheduled for completion by December 9, 2025. The award was made through open competition with no set-aside designation, and the product will be delivered to AmerisourceBergen's facility...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on November 18, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a biologic immunosuppressant medication used to treat rheumatoid arthritis and other inflammatory conditions. The order, valued at $2,387.94 with a firm fixed price structure, will be fulfilled from the contractor's Conshohocken, Pennsylvania facility and is scheduled for completion by November 19, 2025. This is a non-set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a prescribed injectable medication used to treat rheumatoid arthritis and other inflammatory conditions. This competitively awarded, non-set-aside delivery order carries a ceiling value of $7,470.37 under firm fixed price terms, with an ultimate completion date of December 9, 2025. The order will be fulfilled from AmerisourceBergen's facility...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, valued at $52,706.28, is scheduled for completion by August 12, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The contract received no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $17,041.94 to AmerisourceBergen Drug Corp for the supply of HUMIRA Pen 40 mg/0.8 mL on December 11, 2025, with an ultimate completion date of December 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. HUMIRA is a widely-used biologic immunosuppressant medication primarily indicated for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a biologic medication used to treat autoimmune conditions. This firm fixed-price delivery order, valued at $1,591.96, represents a non-competitive set-aside award and is scheduled for completion by December 17, 2025. The products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of HUMIRA (adalimumab) Pen 40 mg/0.4 mL, a biologic medication commonly used to treat rheumatoid arthritis, Crohn's disease, and other autoimmune conditions. This competitively awarded, firm fixed-price delivery order has a ceiling value of $2,994.64 and an ultimate completion date of December 2, 2025. The contract is issued under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,361.37 to AmerisourceBergen Drug Corp for the supply of HUMIRA Pen 40 mg/0.8 mL on November 20, 2025, with an ultimate completion date of November 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. HUMIRA is a biologic immunosuppressant medication commonly used to treat autoimmune...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of HUMIRA (Adalimumab) Pen 40 mg/0.4 mL, a biologic immunosuppressant medication used to treat rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, valued at $8,435.70, represents an uncompeted non-set-aside award and is scheduled for completion by July 16, 2025. The contract will be fulfilled from AmerisourceBergen's distribution...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used primarily for treating rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order has a ceiling value of $2,598.96 and an ultimate completion date of August 20, 2025. The award was made without a set-aside designation, indicating it was awarded through open competition. The...